相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification
Carla Montironi et al.
GUT (2023)
Molecular and radiopathologic spectrum between HCC and intrahepatic cholangiocarcinoma
Youngsic Jeon et al.
HEPATOLOGY (2023)
Clinical Significance of the Duality of Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma
Tomoko Aoki et al.
CANCERS (2022)
Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma
Ryu Sasaki et al.
CANCERS (2022)
Therapeutic efficacy of atezolizumab plus bevacizumab for hepatocellular carcinoma with WNT/beta-catenin signal activation
Akifumi Kuwano et al.
ONCOLOGY LETTERS (2022)
The predictive value of tumor infiltrating leukocytes in Hepatocellular Carcinoma: A systematic review and meta-analysis
Markus Bo Schoenberg et al.
EJSO (2021)
Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma
Chia-Lang Hsu et al.
LIVER CANCER (2021)
Higher Enhancement Intrahepatic Nodules on the Hepatobiliary Phase of Gd-EOB-DTPA-Enhanced MRI as a Poor Responsive Marker of Anti-PD-1/PD-L1 Monotherapy for Unresectable Hepatocellular Carcinoma
Tomoko Aoki et al.
LIVER CANCER (2021)
Immunological Microenvironment Predicts the Survival of the Patients with Hepatocellular Carcinoma Treated with Anti-PD-1 Antibody
Masahiro Morita et al.
LIVER CANCER (2021)
Prognostic grade for resecting hepatocellular carcinoma: multicentre retrospective study
T. Takayama et al.
BRITISH JOURNAL OF SURGERY (2021)
The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma
Shunjie Xia et al.
EBIOMEDICINE (2020)
Association between Genetic and Immunological Background of Hepatocellular Carcinoma and Expression of Programmed Cell Death-1
Naoshi Nishida et al.
LIVER CANCER (2020)
A novel scoring method based on RNA-Seq immunograms describing individual cancer-immunity interactions
Yukari Kobayashi et al.
CANCER SCIENCE (2020)
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma
Marina Ruiz de Galarreta et al.
CANCER DISCOVERY (2019)
Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies
James J. Harding et al.
CLINICAL CANCER RESEARCH (2019)
Immune Exclusion-Wnt/CTNNB1 Class Predicts Resistance to Immunotherapies in HCC
Roser Pinyol et al.
CLINICAL CANCER RESEARCH (2019)
Gadoxetic acid-enhanced magnetic resonance imaging reflects co-activation of β-catenin and hepatocyte nuclear factor 4α in hepatocellular carcinoma
Azusa Kitao et al.
HEPATOLOGY RESEARCH (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
Daniela Sia et al.
GASTROENTEROLOGY (2017)
Epithelial-to-Mesenchymal Transition: A Mediator of Sorafenib Resistance in Advanced Hepatocellular Carcinoma
Nabiel Mir et al.
CURRENT CANCER DRUG TARGETS (2017)
Genotype-Phenotype Correlation of CTNNB1 Mutations Reveals Different β-Catenin Activity Associated With Liver Tumor Progression
Sandra Rebouissou et al.
HEPATOLOGY (2016)
Immunohistochemical molecular analysis indicates hepatocellular carcinoma subgroups that reflect tumor aggressiveness
Hanako Tsujikawa et al.
HUMAN PATHOLOGY (2016)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Several immune escape patterns in non-Hodgkin's lymphomas
Camille Laurent et al.
ONCOIMMUNOLOGY (2015)
Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging and Alpha-Fetoprotein Predict Prognosis of Early-Stage Hepatocellular Carcinoma
Taro Yamashita et al.
HEPATOLOGY (2014)
OATP1B3 expression is strongly associated with Wnt/β-catenin signalling and represents the transporter of gadoxetic acid in hepatocellular carcinoma
Akihisa Ueno et al.
JOURNAL OF HEPATOLOGY (2014)
A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma
Meng Yang et al.
JOURNAL OF CELL SCIENCE (2013)
SIFT web server: predicting effects of amino acid substitutions on proteins
Ngak-Leng Sim et al.
NUCLEIC ACIDS RESEARCH (2012)
FoxM1: A Master Regulator of Tumor Metastasis
Pradip Raychaudhuri et al.
CANCER RESEARCH (2011)
Hepatocellular Carcinoma: Hepatocyte-selective Enhancement at Gadoxetic Acid-enhanced MR Imaging-Correlation with Expression of Sinusoidal and Canalicular Transporters and Bile Accumulation
Takahiro Tsuboyama et al.
RADIOLOGY (2010)
Convergence of Wnt Signaling on the HNF4α-Driven Transcription in Controlling Liver Zonation
Marta Colletti et al.
GASTROENTEROLOGY (2009)
Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma
Masato Narita et al.
JOURNAL OF GASTROENTEROLOGY (2009)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
CCL5-enhanced human immature dendritic cell migration through the basement membrane in vitro depends on matrix metalloproteinase-9
Valerie Chabot et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
One thousand fifty-six hepatectomies without mortality in 8 years
H Imamura et al.
ARCHIVES OF SURGERY (2003)